BiOptic Inc.

股票代號 6850

You have 0 products on your cart

Total
$ USD

VIEW CART

PAY Now

Special Promotion by BiOptic USA

Instruments

Instruments

Qsep Series & Qamp

Consumables

Consumables

DNA, RNA & Protein Cartridges

Reagents

Reagents

PCR, RT-PCR

Qexp Test Kits

Qexp Test Kits

MDx, FS Series

BiOptic Inc.

Leader in Innovative Capillary Electrophoresis Products.

BiOptic Inc. is a biotechnology instrumentation company that develops innovative scientific products for research and clinical applications.

High Resolution

High Resolution

DNA sample with 1 bp different can be resolved on Qsep Series platforms

CRISPR/Cas

CRISPR/Cas

CRISPR is a Genome Engineering technique that uses protein to interact with DNA. Genome editing begins with dsDNA cleavage. Cas9 is a dual-RNA-guided dsDNA endonuclease that is programmed by a single chimeric RNA. The guide RNA positions the Cas9 enzyme to the correct position on the target DNA for cleavage.

High Molecular Weight DNA (HMW DNA)

High Molecular Weight DNA (HMW DNA)

With ongoing innovation and improvements in the biotechnology industry now scientists are able to isolate longer and longer lengths of DNA at the high molecular weight (HMW DNA) for genome research. For downstream applications such as third-generation sequencing, the HMW DNA quality becomes an important issue.

Recent News

AMP 2024, British Columbia, Canada

Jul 03, 2024

The AMP 2024 Annual Meeting & Expo is the only educational event developed and presented by internationally renowned molecular diagnostic professionals.

MEDICA 2024, Dusseldorf, Germany

Jul 01, 2024

MEDICA is the world’s largest event for the medical sector. For more than 40 years it has been firmly established on every expert’s calendar. There are many reasons why MEDICA is so unique.

ADLM 2024, CHICAGO IL, USA (7/30-8/1)

Mar 28, 2024

The Association for Diagnostics & Laboratory Medicine (formerly AACC) is a global scientific and medical professional organization dedicated to clinical laboratory science and its application to healthcare.

BiOptic Qampmini Thermal Cycler has received Class I Medical Device Certification!

Dec 21, 2023

BiOptic Qampmini Thermal Cycler has received Class I Medical Device Certification of Taiwan Food and Drug Administration (TFDA)
Qampmini has been listed as a Class I Medical Device in the U.S. Food and Drug Administration (FDA) since JAN 2023, and is now granted by the Taiwan Food and Drug Administration (TFDA). It can be sold as a medical device to demand institutions from the date of grant.

【Congratulations！】BiOptic has received an India invention patent

Dec 18, 2023

BiOptic has received a new invention patent for the Qsep400 Bio-Fragment Analyzer and 4-channel cartridge from India!The biopharmaceutical industry in India is a very important emerging market in the globe. Local R&D investment in the biopharmaceutical industry accounts for 60% of the total investment. Plus, it has become the world's largest vaccine producer and the world's largest manufacturer of generic drugs!

Algorithm for optimized mRNA design improves stability and immunogenicity

Dec 14, 2023

Messenger RNA (mRNA) vaccines are being used to combat the spread of COVID-19(refs. 1–3), but they still exhibit critical limitations caused by mRNA instability and degradation, which are major obstacles for the storage, distribution and efficacy of the vaccine products4. Increasing secondary structure lengthens mRNA half-life, which, together with optimal codons, improves protein expression5.